FDA Approves Supplemental NADA for Ceftiofur Sodium

Summary

The FDA has approved a supplemental new animal drug application (NADA) for ceftiofur sodium, providing revised susceptibility information for food-animal pathogens, following a submission by Pharmacia and Upjohn Co.